Lin, Daniel W <br/><br/>
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.  [electronic resource] 

 -  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology  Sep 2011 
 - 1928-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7755 
<br/><br/><label>Standard No.: </label>10.1158/1055-9965.EPI-11-0236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Armadillo Domain Proteins--genetics<br/>Cell Adhesion Molecules--genetics<br/>Cohort Studies<br/>Cryptochromes--genetics<br/>Endoribonucleases--genetics<br/>Genetic Predisposition to Disease<br/>Genetic Variation<br/>Humans<br/>Interleukin-4--genetics<br/>Male<br/>Middle Aged<br/>Phosphoproteins--genetics<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Prostatic Neoplasms--genetics<br/>Receptors, Leptin--genetics<br/>Risk Factors